2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014
April 28, 2017BeyondSpring Provides Quarterly Operational Update and Full Year 2016 ResultsPrinter Friendly Version
April 26, 2017BeyondSpring to Participate in Joseph Gunnar’s Pioneers 2017 Conference on May 2 in New YorkPrinter Friendly Version
April 25, 2017BeyondSpring Enrolls First U.S. Patient in Phase 2/3 Clinical Trial of Plinabulin for Neutropenia PreventionPrinter Friendly Version
April 13, 2017BeyondSpring to Host Quarterly Operational Update Conference Call on April 28, 2017Printer Friendly Version
March 22, 2017BeyondSpring Chief Medical Officer to Present on Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Prevention at BIO-Europe Spring 2017Printer Friendly Version
March 20, 2017BeyondSpring Lead Asset Plinabulin's Anti-Cancer Mechanism Accepted for Poster Presentation at the 2017 Keystone Symposia in British ColumbiaPrinter Friendly Version
March 14, 2017BeyondSpring Chief Medical Officer to Present Clinical Data for Lead Asset Plinabulin for Non-Small Cell Lung Cancer Treatment and Neutropenia Prevention at 2017 BIO Asia International Conference in TokyoPrinter Friendly Version
March 9, 2017Nasdaq Welcomes BeyondSpring Inc. (Nasdaq: BYSI) to The Nasdaq Stock MarketPrinter Friendly Version
March 9, 2017BeyondSpring Inc. Prices Initial Public Offering and Concurrent Private Placement of $54.31 MPrinter Friendly Version
February 21, 2017BeyondSpring’s Promising Clinical Data for Lead Asset on Non-Small Cell Lung Cancer Treatment Selected for Presentation at 2017 ASCO-SITC Clinical Immuno-Oncology SymposiumPrinter Friendly Version
January 24, 2017FDA Accepts BeyondSpring IND Application for Plinabulin for the Prevention of Chemotherapy-Induced NeutropeniaPrinter Friendly Version
January 10, 2017BeyondSpring Inc. to Present at Biotech Showcase 2017 During Annual JPMorgan Healthcare Conference on January 10 in San FranciscoPrinter Friendly Version
Print Page Print Page | Email Page Email Page | RSS Feeds RSS Feeds | Email Alerts Email Alerts | IR Contacts Contact IR | Financial Tear Sheet Financial Tear Sheet